FDA Lifts Partial Clinical Hold on MDS and AML Magrolimab Studies
Go back to FDA Lifts Partial Clinical Hold on MDS and AML Magrolimab Studies| Gilead Sciences (NASDAQ: GILD) | Delayed: 149.39 -0.53 (0.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $149.92 | 52 Week High | $108.63 | |||
| Open | $150.00 | 52 Week Low | $71.39 | |||
| Day High | $152.55 | P/E | 82.54 | |||
| Day Low | $149.35 | EPS | $1.81 | |||
| Volume | 1,426,037 | |||||
